Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Neuropathy, hereditary sensory and autonomic, type 2A

SCN9A · rs187558439

Strength of the evidence

3 / 4

ClinVar classifies it as disease-causing (or likely), reviewed at 2 of 4 stars.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What ClinVar records

Classification Pathogenic for Neuropathy, hereditary sensory and autonomic, type 2A, Generalized epilepsy with febrile seizures plus, type 7, Channelopathy-associated congenital insensitivity to pain, autosomal recessive; criteria provided, multiple submitters, no conflicts (2 of 4 stars, 4 submitters), last evaluated 2025-10-13. ClinVar record 245799 NM_001365536.1(SCN9A):c.4495C>T (p.Arg1499Ter)

Classification Conflicting classifications of pathogenicity for Primary erythromelalgia, Paroxysmal extreme pain disorder, Channelopathy-associated congenital insensitivity to pain, autosomal recessive, Neuropathy, hereditary sensory and autonomic, type 2A, Generalized epilepsy with febrile seizures plus, type 7 and 2 more; criteria provided, conflicting classifications (1 of 4 stars, 7 submitters), last evaluated 2026-03-03. ClinVar record 331963 NM_001365536.1(SCN9A):c.4495C>A (p.Arg1499=)

Change history MyGeneLog™ keeps a copy of every weekly release from 2026-10-19 and compares them. This position's classification has not changed since.

What this is ClinVar's aggregate record for this position (as of its 2026-11-16 release), not a result about you. A classification describes the variant against the condition named, as laboratories submitted it. Whether a person carries this variant, and what that would mean for them, is a question for a clinical test and a genetic counsellor.

How common each version is

AGT
Japanese ToMMo
G 100.0%
World 1000 Genomes
G 100.0% · T 0.0%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. No Korean figure for this position yet.

What each result means

A/A Two copies of the version ClinVar lists as disease-causing for Neuropathy, hereditary sensory and autonomic, type 2A. A result like this should be confirmed by a medical genetic test and talked through with a doctor; consumer DNA files can misread rare variants. (ClinVar VCV000245799, criteria provided, multiple submitters, no conflicts)
A/G One copy of the version ClinVar lists as disease-causing for Neuropathy, hereditary sensory and autonomic, type 2A. Some conditions need only one copy; for others, one copy makes a person a carrier who is usually healthy but can pass it on. A genetic counsellor can say which applies. (ClinVar VCV000245799, criteria provided, multiple submitters, no conflicts)
G/G No copy of the version ClinVar lists as disease-causing for Neuropathy, hereditary sensory and autonomic, type 2A. This is the usual result. (ClinVar VCV000245799, criteria provided, multiple submitters, no conflicts)

Source: ClinVar VCV000245799, criteria provided, multiple submitters, no conflicts

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Neuropathy, hereditary sensory and autonomic, type 2A (rs187558439). MyGeneLog™. https://www.mygenelog.com/variants/rs187558439

← See all variants